Rituximab for Pediatric Renal Transplant Rejection
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
Rituximab will be tested for its safety and potential efficacy in treating B cell dense renal
allograft rejection episodes in children receiving renal transplants at Stanford University